These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26340513)

  • 1. Effects of LSD on grooming behavior in serotonin transporter heterozygous (Sert⁺/⁻) mice.
    Kyzar EJ; Stewart AM; Kalueff AV
    Behav Brain Res; 2016 Jan; 296():47-52. PubMed ID: 26340513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in grooming activity and syntax in heterozygous SERT and BDNF knockout mice: the utility of behavior-recognition tools to characterize mutant mouse phenotypes.
    Kyzar EJ; Pham M; Roth A; Cachat J; Green J; Gaikwad S; Kalueff AV
    Brain Res Bull; 2012 Dec; 89(5-6):168-76. PubMed ID: 22951260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marked decrease of LSD-induced stimulus control in serotonin transporter knockout mice.
    Krall CM; Richards JB; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 2008 Jan; 88(3):349-57. PubMed ID: 17935763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the 5-HT
    Preller KH; Schilbach L; Pokorny T; Flemming J; Seifritz E; Vollenweider FX
    J Neurosci; 2018 Apr; 38(14):3603-3611. PubMed ID: 29555857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice.
    Kalueff AV; Fox MA; Gallagher PS; Murphy DL
    Genes Brain Behav; 2007 Jun; 6(4):389-400. PubMed ID: 16939636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice.
    Fox MA; Jensen CL; Gallagher PS; Murphy DL
    Neuropharmacology; 2007 Oct; 53(5):643-56. PubMed ID: 17765930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An animal behavior model for studying the actions of LSD and related hallucinogens.
    Jacobs BL; Trulson ME; Stern WC
    Science; 1976 Nov; 194(4266):741-3. PubMed ID: 982043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1.
    Rodriguiz RM; Nadkarni V; Means CR; Pogorelov VM; Chiu YT; Roth BL; Wetsel WC
    Sci Rep; 2021 Sep; 11(1):17690. PubMed ID: 34480046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing action of LSD on neuronal responsiveness to serotonin in a brain structure involved in obsessive-compulsive disorder.
    Zghoul T; Blier P
    Int J Neuropsychopharmacol; 2003 Mar; 6(1):13-21. PubMed ID: 12899732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ; Aghajanian GK
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient mice.
    Fox MA; Jensen CL; French HT; Stein AR; Huang SJ; Tolliver TJ; Murphy DL
    Psychopharmacology (Berl); 2008 Dec; 201(2):203-18. PubMed ID: 18712364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.
    De Gregorio D; Comai S; Posa L; Gobbi G
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
    Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
    Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral effects of LSD in the cat: proposal of an animal behavior model for studying the actions of hallucinogenic drugs.
    Jacobs BL; Trulson ME; Stern WC
    Brain Res; 1977 Aug; 132(2):301-14. PubMed ID: 19128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LSD acts synergistically with serotonin depletion: evidence from behavioral studies in cats.
    Trulson ME; Jacobs BL
    Pharmacol Biochem Behav; 1976 Mar; 4(3):231-4. PubMed ID: 132670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline.
    De Gregorio D; Inserra A; Enns JP; Markopoulos A; Pileggi M; El Rahimy Y; Lopez-Canul M; Comai S; Gobbi G
    Neuropsychopharmacology; 2022 May; 47(6):1188-1198. PubMed ID: 35301424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist-directed signaling of serotonin 5-HT2C receptors: differences between serotonin and lysergic acid diethylamide (LSD).
    Backstrom JR; Chang MS; Chu H; Niswender CM; Sanders-Bush E
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):77S-81S. PubMed ID: 10432492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin 5-HT
    O'Reilly KC; Connor M; Pierson J; Shuffrey LC; Blakely RD; Ahmari SE; Veenstra-VanderWeele J
    Psychopharmacology (Berl); 2021 Apr; 238(4):1111-1120. PubMed ID: 33511450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of Lysergic Acid Diethylamide (LSD) on the Positive Valence Systems: A Research Domain Criteria (RDoC)-Informed Systematic Review.
    Pouyan N; Younesi Sisi F; Kargar A; Scheidegger M; McIntyre RS; Morrow JD
    CNS Drugs; 2023 Dec; 37(12):1027-1063. PubMed ID: 37999867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.